Price at Close
Change:
Volume:
×
Buy Stock
Remote Buying of Actinium Pharmaceuticals Inc through IEX is under development on ETFS.com.
Notify Me when it is ready×
Sell Stock
Remote Selling of Actinium Pharmaceuticals Inc through IEX is under development on ETFS.com.
Notify Me when it is ready- Open
- Previous Close
- Bid
- Ask
- Day Range -
- 52 Week Range -
- Volume
- Avg. Volume
- Volume to USD
- Market Cap
- Beta
- PE Ratio
- Latest EPS
- EPS TTM
- Dividend
- Dividend Yield
- Ex-Dividend Date
- Revenue TTM
- Revenue per Share
- Revenue per Employee
- Profit Margin
- Gross Profit TTM
- Total Cash TTM
- Total Debt TTM
Share Distribution
- Shares Outstanding
- Float
- Short Interest
- Short Ratio
- Insider Ownership
- Institution Ownership
Latest Headlines
Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target Raised to $650.00 via ETF Daily News
Stratos Wealth Advisors LLC Buys New Position in iShares U.S. Healthcare ETF (NYSEARCA:IYH) via ETF Daily News
MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH Sells 3,225 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) via ETF Daily News
Insider Selling: AMN Healthcare Services, Inc. (NYSE:AMN) Insider Sells 4,515 Shares of Stock via ETF Daily News
Cipher Pharmaceuticals (TSE:CPH) Share Price Passes Below 50 Day Moving Average of $3.59 via ETF Daily News
FY2026 EPS Estimates for Milestone Pharmaceuticals Inc. (NASDAQ:MIST) Raised by HC Wainwright via ETF Daily News
ACADIA Pharmaceuticals (NASDAQ:ACAD) Shares Pass Above 200 Day Moving Average of $17.29 via ETF Daily News
Fusion Pharmaceuticals (NASDAQ:FUSN) Stock Rating Reaffirmed by B. Riley via ETF Daily News
Satsuma Pharmaceuticals (NASDAQ:STSA) Given “Neutral” Rating at Mizuho via ETF Daily News
Financial Contrast: AlerisLife (NASDAQ:ALR) versus National HealthCare (NYSE:NHC) via ETF Daily News
Actinium Pharmaceuticals Inc Performance
Active Alerts for IEX:ATNM
You don't have any alerts set for IEX:ATNM.
About Actinium Pharmaceuticals Inc
Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of innovative-targeted therapies for patients with cancers lacking effective treatment options. The company's product portfolio includes Iomab-B and Actimab-A.
Real-time ATNM to USD Trade Analysis on IEX
Market Status Closed
Analysis is available when the exchange & market are open.